Evaluation of amphotericin B and micafungin combination against clinical isolates of Aspergillus species.

Nishi, I; Sunada, A; Toyokawa, M; Asari, S; Iwatani, Y

Nishi, I; Sunada, A; Toyokawa, M; Asari, S; Iwatani, Y.

Affiliation

Nishi I; Laboratory for Clinical Investigation, Osaka University Hospital, 2-15 Yamadaoka, Suita, Osaka 565-0871, Japan. nishi@hp-lab.med.osaka-u.ac.jp

J Chemother ; 23(2): 102-6, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21571627

Subject(s)

Amphotericin B/pharmacology; Antifungal Agents/pharmacology; Aspergillus/drug effects; Echinocandins/pharmacology; Lipopeptides/pharmacology; Amphotericin B/therapeutic use; Antifungal Agents/therapeutic use; Aspergillosis/drug therapy; Aspergillosis/microbiology; Aspergillus/isolation & purification; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Echinocandins/therapeutic use; Humans; Lipopeptides/therapeutic use; Micafungin; Microbial Sensitivity Tests/methods

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aspergillus / Amphotericin B / Echinocandins / Lipopeptides / Antifungal Agents Limits: Humans Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links